ACON aclarion.com: Multiplikator Forward P/S

Logo grafis Aclarion Corp (ACON)

Can the implementation of AI analysis for chronic pain diagnostics drive business growth? Stable demand for medtech, regardless of economic conditions, confirms the resilience of Aclarion (ACON). The development of MR spectroscopy systems in the US objectifies the causes of diseases. The future P/S metric demonstrates illiquidity risks during a sharp surge in quotes, where the current metric equals 46.20.

aclarion.com - Rasio kapitalisasi marang dodolan sing dikarepake ACON (periode 28.04.2023 - 13.11.2026)

Rincian metrik lan analitis perusahaan Aclarion Corporation (ACON)

- rega saiki lan proyeksi nilai saham:
Rega saham Aclarion, Inc.|ACON - Rata-rata rega prakiraan
- data kapitalisasi saham perusahaan:
Kapitalisasi pasar Aclarion Corporation|ACON - Nilai Bisnis
- statistik nilai buku emiten:
Nilai Buku saben Saham Aclarion|ACON - Pambiji Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku aclarion.com|ACON - Gunggung Aset Perusahaan
- indikator total utang lan likuiditas perusahaan:
Total Utang marang Modal Aclarion|ACON - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas Aclarion|ACON - Utang perusahaan|Utang marang nilai buku Aclarion Corporation|ACON - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Aclarion|Likuiditas cepet aclarion.com
- rincian asil keuangan lan kelipatan valuasi:
ACON - Bathi resik taunan|Bathi mangsa ngarep Aclarion|ACON - Pangali P/E|Pangali Forward P/E Aclarion Corp|ACON - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Aclarion Corporation|ACON - Bathi sadurunge ngurangi bunga, pajak, penyusutan, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan Aclarion|ACON - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi EPS kuartalan aclarion.com|ACON - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi resik saben saham kanggo taun ngarep Aclarion
- indikator volume dodolan lan pendapatan:
ACON - Volume dodolan perusahaan|Volume dodolan mangsa ngarep perusahaan Aclarion, Inc.|ACON - Kapitalisasi marang volume dodolan|Multiplikator Forward P/S Aclarion Corporation
Ringkesan analitik perusahaan:Aclarion, Inc. (ACON)
Sampel barang Aclarion

To find fundamental support for Aclarion (ACON), it is essential to evaluate the ratio of market capitalization to expected revenue, which reflects investors' future expectations for business scaling. By analyzing the forward P/S trend, you can see how the accuracy of Nociscan algorithms and the confirmation of ROI for surgeons translate into market value, determining the degree to which the asset is overbought relative to its potential in back pain diagnostics.

Pesaing wigati

Multiplikator Forward P/S ABT (Abbott)|Thermo Fisher Scientific Inc. (TMO) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|GE Healthcare Corp - Multiplikator Forward P/S|MTD (Mettler Toledo Inc) - Kapitalisasi marang prakiraan pendapatan|WAT: Multiplikator Forward P/S|TECH - Rasio kapitalisasi marang dodolan sing dikarepake|BRKR (Bruker) - Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Azenta Inc (AZTA)|Multiplikator Forward P/S VREX|Multiplikator Forward P/S Semler (SMLR)|Rasio rega marang prakiraan pendapatan Butterfly Network, Inc. BFLY|mesalabs.com - Rasio rega marang prakiraan pendapatan|QSI: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan NNOX (Nano-X Imaging)|QTRX: Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep 908 Devices Corporation (MASS)|Rasio rega marang prakiraan pendapatan CapsoVision, Inc.|MXCT - Prakiraan rega marang pendapatan|Multiplikator forward rega marang pendapatan RPID (Rapid Micro Biosystems)|Multiplikator Forward P/S Seer Inc (SEER)|Multiplikator Forward P/S HYPR (Hyperfine Corp)|Rasio kapitalisasi marang dodolan sing dikarepake FONAR Corporation Inc (FONR)|DXR - Rasio rega marang prakiraan pendapatan|Rega mangsa ngarep marang pendapatan MDAI|VivoSim Labs Inc (VIVS) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Akoya Biosciences, Inc.|THMO (ThermoGenesis Holdings Inc.) - Multiplikator Forward P/S|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Talis Biomedical Corp TLIS|Rasio rega marang prakiraan pendapatan T2 Biosystems, Inc. (TTOO)